What is Amphastar Pharmaceuticals's debt-to-equity?

Amphastar Pharmaceuticals (AMPH) reported debt-to-equity of 0.2× in Q4 2021.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Amphastar Pharmaceuticals AMPH Debt-to-equity

Discontinued — last reported Q4 '21

Debt-to-equity at other companies

PfizerPFE

0.7×0.0×

Halozyme TherapeuticsHALO

9.9×+6.7×

ViatrisVTRS

1×+0.1×

Opko HealthOPK

0×0.0×

AptarGroupATR

0.5×+0.1×

ARS Pharmaceuticals, Inc.SPRY

1.6×+1.6×

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.4%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

total debt/total stockholders equity=0.2×

Based on the most recent quarter.

The official record: Amphastar Pharmaceuticals’s 10-K, filed March 1, 2023, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's debt-to-equity?: Amphastar Pharmaceuticals (AMPH) reported debt-to-equity of 0.2× in Q4 2021.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.